Di Noia, Vincenzo Pio
 Distribuzione geografica
Continente #
NA - Nord America 298
EU - Europa 199
AS - Asia 84
AF - Africa 9
SA - Sud America 1
Totale 591
Nazione #
US - Stati Uniti d'America 295
SE - Svezia 61
IT - Italia 51
CN - Cina 31
SG - Singapore 31
FR - Francia 18
IE - Irlanda 16
DE - Germania 15
IN - India 10
CI - Costa d'Avorio 9
ID - Indonesia 9
BE - Belgio 8
CZ - Repubblica Ceca 5
FI - Finlandia 5
RU - Federazione Russa 4
AT - Austria 3
CA - Canada 3
RO - Romania 3
UA - Ucraina 3
GB - Regno Unito 2
IR - Iran 2
BR - Brasile 1
BY - Bielorussia 1
ES - Italia 1
KG - Kirghizistan 1
LT - Lituania 1
MD - Moldavia 1
NL - Olanda 1
Totale 591
Città #
Chandler 83
Cattolica 26
Singapore 24
Ann Arbor 22
Ashburn 22
Dublin 16
Redmond 15
Abidjan 9
Jakarta 9
Marseille 9
San Mateo 9
Brussels 8
Boardman 7
Boston 7
Princeton 7
Dearborn 6
Brno 5
Bremen 4
Jacksonville 4
Rome 4
Wilmington 4
Detroit 3
Helsinki 3
Milan 3
Moscow 3
Nanchang 3
Nanjing 3
Norwalk 3
Tianjin 3
Toronto 3
Andover 2
Council Bluffs 2
Fairfield 2
Guangzhou 2
Ladispoli 2
Lawrence 2
New Haven 2
Vienna 2
Beijing 1
Bishkek 1
Cervignano del Friuli 1
Changsha 1
Chicago 1
Chisinau 1
Civitanova Marche 1
Delhi 1
Fremont 1
Groningen 1
Gurgaon 1
Houston 1
Hyderabad 1
Itaguaí 1
Jiaxing 1
Kashan 1
Kish 1
Lancaster 1
London 1
Los Angeles 1
Munich 1
Nuoro 1
Palermo 1
Phoenix 1
Quanzhou 1
Redwood City 1
Reghin 1
Seattle 1
Shenyang 1
Starnberg 1
Tappahannock 1
Woodbridge 1
Zhengzhou 1
Totale 376
Nome #
Are TKIs favourable for the elderly with non-small-cell lung cancer? 108
Is surgery mandatory in locally advanced gastrointestinal stromal tumors after imatinib? A case report and literature review. 86
Blood serum amyloid A as potential biomarker of pembrolizumab efficacy for patients affected by advanced non-small cell lung cancer overexpressing PD-L1: results of the exploratory “FoRECATT” study 76
Transradial versus Transfemoral Access for Hepatic Chemoembolization: Intrapatient Prospective Single-Center Study 69
PTEN Loss as a Predictor of Tumor Heterogeneity and Poor Prognosis in Patients With EGFR-mutant Advanced Non–small-cell Lung Cancer Receiving Tyrosine Kinase Inhibitors 58
Exploring the molecular and biological background of lung neuroendocrine tumours 57
Molecular Testing in EBUS-TBNA Specimens of Lung Adenocarcinoma: A Study of Concordance Between Cell Block Method and Liquid-Based Cytology in Appraising Sample Cellularity and EGFR Mutations 54
Oncogene-addicted non-small-cell lung cancer: Treatment opportunities and future perspectives 50
Multisite artery disease: a common and challenging clinical condition calling for specific management 45
Baseline BMI and BMI variation during first line pembrolizumab in NSCLC patients with a PD-L1 expression ≥ 50%: A multicenter study with external validation 4
Totale 607
Categoria #
all - tutte 3.192
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.192


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202019 0 0 0 0 0 0 0 0 1 0 10 8
2020/202137 6 2 0 0 5 2 2 2 3 1 10 4
2021/2022102 25 1 1 9 7 2 0 12 4 1 13 27
2022/2023215 24 27 22 42 9 32 18 13 21 1 2 4
2023/202475 0 31 2 2 0 4 4 5 2 2 9 14
2024/202574 10 5 17 12 12 4 8 6 0 0 0 0
Totale 607